Clinical trial efforts in Alzheimer disease Why test statins?

被引：4

作者：

Arvanitakis, Zoe ^{[1
,2
]}

Knopman, David S. ^{[3
]}

机构：

[1] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA

[2] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA

[3] Mayo Clin, Dept Neurol, Rochester, MN USA

来源：

NEUROLOGY | 2010年 / 74卷 / 12期

关键词：

RISK; NEUROPATHOLOGY;

D O I：

10.1212/WNL.0b013e3181d6479a

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

100204 [神经病学];

摘要：

引用

收藏

页码：945 / 946

页数：2

相关论文

共 10 条

[1]

[Anonymous], WORLD ALZH REP 2009

[2]

Statins, incident Alzheimer disease, change in cognitive function, and neuropathology [J].

Arvanitakis, Z. ;

Schneider, J. A. ;

Wilson, R. S. ;

Bienias, J. L. ;

Kelly, J. F. ;

Evans, D. A. ;

Bennett, D. A. .

NEUROLOGY, 2008, 70 (19) :1795-1802

[3]

CHERRY DK, 2006, NATL HLTH STAT REPOR, V3

[4]

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease LEADe [J].

Feldman, H. H. ;

Doody, R. S. ;

Kivipelto, M. ;

Sparks, D. L. ;

Waters, D. D. ;

Jones, R. W. ;

Schwam, E. ;

Schindler, R. ;

Hey-Hadavi, J. ;

DeMicco, D. A. ;

Breazna, A. .

NEUROLOGY, 2010, 74 (12) :956-964

[5]

Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study [J].

Haag, M. D. M. ;

Hofman, A. ;

Koudstaal, P. J. ;

Stricker, B. H. C. ;

Breteler, M. M. B. .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (01) :13-17

[6]

Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials [J].

Ioannidis, JPA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (04) :281-286

[7]

Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: The ARIC MRI Study [J].

Knopman, David S. ;

Mosley, Thomas H. ;

Catellier, Diane J. ;

Coker, Laura H. .

ALZHEIMERS & DEMENTIA, 2009, 5 (03) :207-214

[8]

The Neuropathology of Probable Alzheimer Disease and Mild Cognitive Impairment [J].

Schneider, Julie A. ;

Arvanitakis, Zoe ;

Leurgans, Sue E. ;

Bennett, David A. .

ANNALS OF NEUROLOGY, 2009, 66 (02) :200-208

[9]

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial [J].

Shepherd, J ;

Blauw, GJ ;

Murphy, MB ;

Bollen, ELEM ;

Buckley, BM ;

Cobbe, SM ;

Ford, I ;

Gaw, A ;

Hyland, M ;

Jukema, JW ;

Kamper, AM ;

Macfarlane, PW ;

Meinders, AE ;

Norrie, J ;

Packard, CJ ;

Perry, IJ ;

Stott, DJ ;

Sweeney, BJ ;

Twomey, C ;

Westendorp, RGJ .

LANCET, 2002, 360 (9346) :1623-1630

[10]

Atorvastatin for the treatment of mild to moderate Alzheimer disease - Preliminary results [J].

Sparks, DL ;

Sabbagh, MN ;

Connor, DJ ;

Lopez, J ;

Launer, LJ ;

Browne, P ;

Wasser, D ;

Johnson-Traver, S ;

Lochhead, J ;

Ziolwolski, C .

ARCHIVES OF NEUROLOGY, 2005, 62 (05) :753-757